Fredun Pharmaceuticals Ltd presented an investor update in June 2025, showcasing their diverse product portfolio of 697 registered products across 52 countries, with 83% domestic and 17% export revenue mix, and highlighting their unique position in the market as they are the only player in India with a patent for Bone Graft.